WASHINGTON, June 9 /U.S. Newswire/ -- Bavarian Nordic, the Danish biopharmaceutical company developing a new, safer smallpox vaccine, today said that the results of an animal study have confirmed that the vaccine, Imvamune TM, provides the same level of protection as traditional vaccines.
